NPCE · ISSUER CIK 1528287
NeuroPace Inc
Between Aug 1, 2026 and Oct 29, 2026, 3 NeuroPace Inc insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 25, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 202616:31 | Sep 24, 2026 | NPCE | CHIEF MEDICAL OFFICER | F · Tax | $13.97 | −335 | 51,357 | -1% | $5K | ||
| Sep 21, 202616:56 | Sep 20, 2026 | NPCE | Chief Financial Officer | F · Tax | $14.28 | −1,162 | 67,508 | -2% | $17K | ||
| Sep 4, 202617:42 | Sep 3, 2026 | NPCE | CHIEF EXECUTIVE OFFICER, Director | F · Tax | $14.75 | −1,310 | 138,000 | -1% | $19K | ||
| Aug 28, 202617:04 | Aug 27, 2026 | NPCE | CHIEF EXECUTIVE OFFICER, Director | F · Tax | $14.13 | −1,126 | 139,310 | -1% | $16K | ||
| Aug 28, 202617:03 | Aug 27, 2026 | NPCE | CHIEF MEDICAL OFFICER | F · Tax | $14.13 | −358 | 51,692 | -1% | $5K |